WHO Guideline on the Use of GLP-1 Therapies for the Treatment of Obesity in Adults (2025)

What this means for Indian patients

This source is India-specific. It directly reflects the clinical landscape, patient demographics, and guideline context that apply to Indian patients considering GLP-1 therapy. The findings are part of the evidence base GLP-1 Check uses for Indian-guideline-based eligibility assessment — meaning if you are an Indian patient, the conclusions here apply to you with minimal extrapolation.